EMERGENT BIOSOLUTIONS INC. Gain (Loss) on Extinguishment of Debt
EMERGENT BIOSOLUTIONS INC. (EBS) reported Gain (Loss) on Extinguishment of Debt of -$20.50 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:GainsLossesOnExtinguishmentOfDebt · last filed 2026-08-06
- EMERGENT BIOSOLUTIONS INC. gain (loss) on extinguishment of debt for the quarter ending 2026-06-30 was -$20.50M.
- EMERGENT BIOSOLUTIONS INC. gain (loss) on extinguishment of debt for the quarter ending 2025-12-31 was -$13.30M.
- EMERGENT BIOSOLUTIONS INC. gain (loss) on extinguishment of debt for the quarter ending 2025-09-30 was $1.10M, a 266.67% increase year-over-year.
- EMERGENT BIOSOLUTIONS INC. gain (loss) on extinguishment of debt for the quarter ending 2025-06-30 was $0.00.
- EMERGENT BIOSOLUTIONS INC. gain (loss) on extinguishment of debt for fiscal 2025 was -$12.20M, a 2133.33% decline from fiscal 2024.
- EMERGENT BIOSOLUTIONS INC. gain (loss) on extinguishment of debt for fiscal 2024 was $600.00K, a 76.00% decline from fiscal 2023.
- EMERGENT BIOSOLUTIONS INC. gain (loss) on extinguishment of debt for fiscal 2023 was $2.50M.
- EMERGENT BIOSOLUTIONS INC. gain (loss) on extinguishment of debt for fiscal 2022 was $0.00.
| Period end | Gain (Loss) on Extinguishment of Debt 3 month | Gain (Loss) on Extinguishment of Debt 6 month | Gain (Loss) on Extinguishment of Debt 9 month | Gain (Loss) on Extinguishment of Debt 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$20.50M 10-Q · filed 2026-08-06 | -$20.50M 10-Q · filed 2026-08-06 | ||
| 2025-12-31 | -$13.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$12.20M derived: sum of 2 quarters · filed 2026-02-27 | -$12.20M derived: sum of 3 quarters · filed 2026-08-06 | -$12.20M 10-K · filed 2026-02-27 |
| 2025-09-30 | $1.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $1.10M derived: sum of 2 quarters · filed 2026-08-06 | $1.10M 10-Q · filed 2025-10-30 | $1.10M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $0.00 10-Q · filed 2026-08-06 | $0.00 10-Q · filed 2026-08-06 | $0.00 derived: sum of 3 quarters · filed 2026-08-06 | $300.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-08 | $0.00 derived: sum of 2 quarters · filed 2026-02-27 | $300.00K derived: sum of 3 quarters · filed 2026-02-27 | $300.00K derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $300.00K derived: sum of 2 quarters · filed 2026-02-27 | $300.00K derived: sum of 3 quarters · filed 2026-02-27 | $600.00K 10-K · filed 2026-02-27 |
| 2024-09-30 | $300.00K 10-Q · filed 2024-11-07 | $300.00K derived: sum of 2 quarters · filed 2025-08-07 | $600.00K 10-Q · filed 2025-10-30 | $3.10M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $300.00K 10-Q · filed 2025-08-07 | $2.80M derived: sum of 3 quarters · filed 2026-02-27 | $2.80M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $300.00K 10-Q · filed 2025-05-08 | $2.80M derived: sum of 2 quarters · filed 2026-02-27 | $2.80M derived: sum of 3 quarters · filed 2026-02-27 | $2.80M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $2.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $2.50M derived: sum of 2 quarters · filed 2026-02-27 | $2.50M derived: sum of 3 quarters · filed 2026-02-27 | $2.50M 10-K · filed 2026-02-27 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $0.00 derived: sum of 2 quarters · filed 2024-11-07 | $0.00 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $0.00 10-Q · filed 2024-08-07 | ||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-02 | |||
| 2022-12-31 | $0.00 10-K · filed 2025-03-04 | |||
| 2021-12-31 | $0.00 10-K · filed 2024-03-08 | |||
| 2017-09-30 | $400.00K 10-Q · filed 2017-11-03 | $400.00K 10-Q · filed 2017-11-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |